Cytomegalovirus Retinitis as the First Manifestation of Good Syndrome

Ocul Immunol Inflamm. 2018;26(1):122-124. doi: 10.1080/09273948.2016.1199713. Epub 2016 Aug 11.

Authors

Seung Woo Lee¹, Yong Woo Lee², Jeong Hun Bae²

Affiliations

¹ a Department of Ophthalmology, Gyeongju Hospital , Dongguk University School of Medicine , Gyeongju , Republic of Korea.
² b Department of Ophthalmology , Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine , Seoul , Republic of Korea.

PMID: 27715373
DOI: 10.1080/09273948.2016.1199713

No abstract available

Publication types

Case Reports

MeSH terms

Agammaglobulinemia / diagnosis*
Antiviral Agents / therapeutic use
CD4 Lymphocyte Count
Cyclopentolate / therapeutic use
Cytomegalovirus / genetics
Cytomegalovirus Retinitis / diagnosis*
Cytomegalovirus Retinitis / drug therapy
DNA, Viral / genetics
Drug Therapy, Combination
Fluorescein Angiography
Ganciclovir / therapeutic use
Glucocorticoids / therapeutic use
Humans
Intravitreal Injections
Male
Middle Aged
Mydriatics / therapeutic use
Prednisolone / therapeutic use
Thymoma / diagnosis*
Thymoma / surgery
Thymus Neoplasms / diagnosis*
Thymus Neoplasms / surgery
Tomography, X-Ray Computed
Valganciclovir / therapeutic use

Substances

Antiviral Agents
DNA, Viral
Glucocorticoids
Mydriatics
Prednisolone
Valganciclovir
Cyclopentolate
Ganciclovir